Skip to content

Veradermics MANE Income Statement

TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$28.91M
$4.09M
$33M
$33M
-$33M
$0-100%$146.25K$292.5K$438.75K
$842.75K
$732.5K
-$32.27M
$0
-$32.27M
-$47.58
-$47.58
-$32.27M
$0
$328.5K

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Is Veradermics profitable?
Veradermics is not currently profitable: it reported a net loss of $52.9M over the trailing twelve months.
What is Veradermics 's earnings per share?
Veradermics 's diluted EPS over the trailing twelve months is $-39.63.
Where does Veradermics 's income statement data come from?
Every line is extracted from Veradermics 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.